Cutaneous photodamage in schizophrenia patients

Photodermatology Photoimmunology and Photomedicine

Volumn 24, Issue 6, 2008, Pages 291-295

  Wohl, Yonit ^a,b,c   Aviv, Alex ^a,b   Friedman, Tal ^a,e   Barak, Yoram ^a,d  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c MEDICAL CORPS   (Israel)

^d ABARBANEL MENTAL HEALTH CENTER   (Israel)

^e ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Schizophrenia; Skin photoaging; Sun exposure; Sun safety

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HORMONE; MOOD STABILIZER; NEUROLEPTIC AGENT; PHOTOSENSITIZING AGENT; SUNSCREEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS PARAMETERS; FACE; FEMALE; HAND; HEALTH BEHAVIOR; HEALTH EDUCATION; HUMAN; MALE; PHOTOAGING; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SKIN PIGMENTATION; SKIN PROTECTION; SUN EXPOSURE;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOSENSITIVITY DISORDERS; SCHIZOPHRENIA; SKIN; SKIN PIGMENTATION;

EID: 56349107395     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2008.00378.x     Document Type: Article

References (31)

1. Gilchrest BA. Skin aging and photoaging: An overview. J Am Acad Dermatol 1989; 21: 610-613.
2. Grant WB, Strange RC, Garland CF. Sunshine is good medicine. The health benefits of ultraviolet B induced vitamin D production. J Cosmet Dermatol 2003; 86-98.
3. Lucas RM, Repacholi MH, McMichael AJ. Is the current public health message on UV exposure correct? Bull World Health Organ 2006; 84: 485-491.
4. Kendell RE, Adams W. Exposure to sunlight, vitamin D and schizophrenia. Schizophr Res 2002; 54: 193-198.
5. McGrath J, Selten JP, Chant D. Long-term trends in sunshine duration and its association with schizophrenia birth rates and age at first registration - data from Australia and the Netherlands. Schizophr Res 2002; 54: 199-212.
6. Dixon I, Weiden P, Delahanty J, et al. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 2000; 26: 903-912.
7. McCreadie RG. Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study. Br J Psychiatry 2003; 183: 534-539.
8. Saari K, Jokelainen J, Veijola J, et al. Serum lipids in schizophrenia and other functional psychoses: A general population northern Finland 1966 birth cohort survey. Acta Psychiatr Scand 2004; 110: 279-285.
9. Lichtermann D, Ekelund J, Pukkala E, Tanskanen A, Lonnqvist J. Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry 2001; 58: 573-578.
10. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177: 212-217.
11. Osby U, Correia N, Brandt L, Ekbom A, Sparen P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res 2000; 45: 21-28.
12. Roick C, Fritz-Wieacker A, Matschinger H, et al. Health habits of patients with schizophrenia. Soc Phychiatry Psychiatr Epidemiol 2007; 42: 268-276.
13. Fitzpatrick TB. The validity and practicality of sun reactive skin type 1 through 6. Arch Dermatol 1988; 124: 869.
14. Glogau RG, Matarasso SL. Chemical peels. Trichloroacetic acid and phenol. Dermatol Clin 1995; 13: 263-276.
15. Lemperle G, Holmes R, Cohen SR, Lemperle S. A classification of facial wrinkles. Plast Reconstr Surg 2001; 108: 1735-1750.
16. SAS/STAT Users' guide, version 8.; Vols 1, 2. Cary, N C: SAS Institute, 1994.
17. Lewis DA, Lieberman JA. Catching up on schizophrenia: Natural history and neurobiology. Neuron 2000; 28: 325-334.
18. Jeste DV, Twamley EW, Eyler Zorrilla LT, Golshan S, Patterson TL, Palmer BW. Aging and outcome in schizophrenia. Acta Psychiatr Scand 2003; 107: 336-343.
19. Jackson R. Eldery and sun-affected skin. Can Fam Physician 2001; 47: 1236-1244.
20. Davis BE, Koh HK. Faces going up in smoke. A dermatologic opportunity for cancer prevention. Arch Dermatol 1992; 128: 1106.
21. Smith JB, Fenske NA. Cutaneous manifestations and consequences of smoking. J Am Acad Dermatol 1996; 34: 717-732; quiz 733-734 (review).
22. Daniell HW. Smoker's wrinkles. A study in the epidemiology of "crow's feet". Ann Intern Med 1971; 75: 873-880.
23. Kadunce DP, Burr R, Gress R, Kanner R, Lyon JL, Zone JJ. Cigarette smoking: Risk factor for premature facial wrinkling. Ann Intern Med 1991; 114: 840-844.
24. Ernster VL, Grady D, Miike R, Black D, Selby J, Kerlikowske K. Facial wrinkling in men and women, by smoking status. Am J Public Health 1995; 85: 78-82.
25. Weinberger AH, Sacco KA, Creeden CL, Vessicchio JC, Jatlow PI, George TP. Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia. Schizophr Res 2007; 91: 217-225.
26. Gurpegui M, Martinez-Ortega JM, Jurado D, Aguilar MC, Diaz FJ, de Leon J. Subjective effects and the main reason for smoking in outpatients with schizophrenia: A case-control study. Compr Psychiatry 2007; 48: 186-191.
27. Harth Y, Rapaport M. Photosensitivity associated with antipsychotics, antidepressants and anxiolytics. Drug Saf 1996; 14: 252-259.
28. Warnock JK, Morris DW. Adverse cutaneous reactions to antipsychotics. Am J Clin Dermatol 2002; 3: 629-636.
29. Almond DS, Rhodes LE, Pirmohamed M. Risperidone-induced photosensitivity. Postgrad Med J 1998; 74: 252-253.
30. Llambrich A, Lecha M. Photoinduced lichenoid reaction by thioridazine. Photodermatol Photoimmunol Photomed 2004; 20: 108-109.
31. Lovell CR, Cronin E, Rhodes EL. Photocontact urticaria from chlorpromazine. Contact Dermatitis 1986; 14: 290-291.